Phathom Pharmaceuticals, Inc. (PHAT) Financials

$8.04

south_east -$0.07 (-0.8%)
Day's range
$7.85
Day's range
$8.19

PHAT Income statement / Annual

Last year (2023), Phathom Pharmaceuticals, Inc.'s total revenue was $682,000.00, and the percentage change from the previous year is not available. In 2023, Phathom Pharmaceuticals, Inc.'s net income was -$201.59 M. See Phathom Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $682,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $167,000.00 $620,000.00 $521,000.00 $300,000.00 $8,000.00 $0.00
Gross Profit $515,000.00 -$620,000.00 -$521,000.00 -$300,000.00 -$8,000.00 $0.00
Gross Profit Ratio 0.76 0 0 0 0 0
Research and Development Expenses $49.90 M $71.44 M $72.34 M $98.15 M $99.27 M $20,000.00
General & Administrative Expenses $0.00 $101.00 M $62.74 M $27.52 M $6.94 M $1.21 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $117.93 M $101.00 M $62.74 M $27.52 M $6.94 M $1.21 M
Other Expenses $0.00 -$110,000.00 -$2.06 M -$8,000.00 -$49.56 M -$50,000.00
Operating Expenses $167.83 M $172.44 M $135.08 M $125.67 M $106.22 M $1.23 M
Cost And Expenses $167.99 M $172.44 M $135.08 M $125.67 M $106.22 M $1.23 M
Interest Income $7.88 M $2.13 M $41,000.00 $1.09 M $1.09 M $0.00
Interest Expense $41.97 M $27.31 M $6.79 M $4.58 M $4.18 M $13,000.00
Depreciation & Amortization $575,000.00 $620,000.00 $521,000.00 $300,000.00 $8,000.00 $1.23 M
EBITDA -$159.05 M -$171.82 M -$134.56 M -$124.19 M -$250.95 M -$50,000.00
EBITDA Ratio -233.21 0 0 0 0 0
Operating Income Ratio -245.33 0 0 0 0 0
Total Other Income/Expenses Net -$34.28 M -$25.28 M -$8.80 M -$3.40 M -$148.92 M -$63,000.00
Income Before Tax -$201.59 M -$197.72 M -$143.88 M -$129.07 M -$255.13 M -$1.29 M
Income Before Tax Ratio -295.59 0 0 0 0 0
Income Tax Expense $0.00 $25.28 M $4.21 M $4.25 M -$45.39 M $13,000.00
Net Income -$201.59 M -$223.01 M -$148.09 M -$133.32 M -$209.74 M -$1.29 M
Net Income Ratio -295.59 0 0 0 0 0
EPS -3.93 -5.7 -4 -4.01 -8.48 -0.15
EPS Diluted -3.93 -5.7 -4 -4.01 -8.48 -0.15
Weighted Average Shares Out $51.29 M $39.12 M $37.00 M $33.23 M $24.73 M $8.58 M
Weighted Average Shares Out Diluted $51.29 M $39.12 M $37.00 M $33.23 M $24.73 M $8.58 M
Link